Viridian Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$27.19(as of Mar 24, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Viridian Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$27.19
Ticker SymbolVRDN
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees252
CountyUSA
Market Cap$2,822.9M
EBIDTA-362.9M
10-Day Moving Average28.04
P/E Ratio-6.73
20-Day Moving Average28.71
Forward P/E Ratio0.00
50-Day Moving Average30.11
Earnings per Share-3.32
200-Day Moving Average24.20
Profit Margin-91,178.03%
RSI39.39
Shares Outstanding102.2M
ATR1.43
52-Week High34.29
Volume1,383,085
52-Week Low9.90
Most Recent Support Level26.95
Book Value722.2M
Most Recent Resistance Level28.30
P/B Ratio3.19
Upper Keltner31.93
P/S Ratio32.55
Lower Keltner25.49
Debt-to-Equity Ratio31.93
Next Earnings DateUnknown
Cash Surplus141.7M
Next Ex-Dividend DateUnknown

Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. It develops IGF-1R therapies to treat thyroid eye disease (TED), including Veligrotrug, a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered, and Elegrobart, a low-volume, infrequently dosed subcutaneous IGF-1R. The company also develops an anti-thyroid-stimulating hormone receptor (TSHR) candidate for the treatment of Graves' disease and TED. Its portfolio of engineered inhibitors of the neonatal Fc receptor (FcFn) includes VRDN-006, a highly selective Fc fragment, and VRDN-008, a half-life extended bispecific FcRn inhibitor comprising an GC fragment and an albumin-binding domain designed to prolong IGG suppression. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was incorporated in 2010 and is headquartered in Waltham, Massachusetts.

Viridian Therapeutics Inc In Our Stock Scanner

As of Mar 25, 2026
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.